Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Ibuprofen Children 3 months–12 years Ibuprofen 2% Oral suspension Multichem NZ Limited Meditab Specialities Pvt Limited, Maharashtra, India
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
LaxaCon Macrogol 3350 13125mg Potassium chloride 46.6mg Sodium bicarbonate 178.5mg Sodium chloride 350.7mg Powder for oral solution Actavis New Zealand Limited Strides Arcolab Limited, Bangalore, India
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
LaxaCon-Half Macrogol 3350 6562.5mg Potassium chloride 23.3mg Sodium bicarbonate 89.25mg Sodium chloride 175.35mg Powder for oral solution Actavis New Zealand Limited Strides Arcolab Limited, Bangalore, India
|
Product: Active Ingredients: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Spedra Avanafil 50mg Tablet Te Arai Biofarma Limited Mitsubishi Tanabe Pharma Factory Limited, Osaka, Japan
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Spedra Avanafil 100mg Tablet Te Arai Biofarma Limited Mitsubishi Tanabe Pharma Factory Limited, Osaka, Japan
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Spedra Avanafil 200mg Tablet Te Arai Biofarma Limited Mitsubishi Tanabe Pharma Factory Limited, Osaka, Japan
|
Dated this 15th day of January 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).